Squarepoint’s Agilon Health AGL Stock Holding History

Squarepoint’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$407K	Buy	+3,796	New	+$249K	﹤0.01%	3581
2025 Q4	–	Sell	-743	Closed	-$19.1K	–	4206
2025 Q3	$19.1K	Sell	743 -548	-42%	-$20.7K	﹤0.01%	4290
2025 Q2	$74.2K	Buy	+1,291	New	+$104K	﹤0.01%	4234
2025 Q1	–	Sell	-1,324	Closed	-$115K	–	4497
2024 Q4	$62.9K	Buy	+1,324	New	+$80K	﹤0.01%	4804
2024 Q2	–	Sell	-2,931	Closed	-$418K	–	3997
2024 Q1	$447K	Sell	2,931 -5,157	-64%	-$858K	﹤0.01%	3127
2023 Q4	$2.54M	Buy	+8,088	New	+$2.93M	﹤0.01%	1846
2023 Q3	–	Sell	-5,811	Closed	-$2.52M	–	3737
2023 Q2	$2.52M	Buy	5,811 +4,964	+586%	+$2.79M	0.01%	1515
2023 Q1	$503K	Sell	847 -148	-15%	-$82.9K	﹤0.01%	2295
2022 Q4	$402K	Buy	+995	New	+$467K	﹤0.01%	2414

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Squarepoint's AGL Position: Q2 2026 in Review

Squarepoint opened a new position in Agilon Health (AGL) in Q2 2026: 3,796 shares worth $407K. The stake represents ﹤0.01% of the portfolio and ranks #3581 among its holdings. This is a return to the name: Squarepoint previously reported a position in AGL as recently as Q3 2025.

Squarepoint first reported a position in AGL in Q4 2022 and has held it in 9 quarters since. The position peaked at $2.54M in Q4 2023. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Squarepoint held 3,796 shares of Agilon Health worth $407K as of Q2 2026.
Agilon Health was a new Squarepoint position in Q2 2026.
Agilon Health made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3581 holding.
Squarepoint first reported a position in Agilon Health in Q4 2022 and has held it in 9 quarters since.
Squarepoint's Agilon Health position peaked at $2.54M in Q4 2023.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.